This has been the issue with ZIVO. They have not been staffed to continue on or in a position to raise more cash without massive dilution for well over a decade and this has not stopped them from marching on, shareholders be damned.
“They are not staffed to continue on or in a position to raising more cash without massive dilution”
Looks like some "itchy" hands dumping some ZIVO today.
Not surprising really. Was wondering when it was going to happen given ZIVO pretty much gone dark again. Unfortunate but chart watchers will see a breakdown here unless it bounces back above $8.50 and holds.
Merge the whole company with a large pharma company Acquiring company pays a small portion in cash (enough to payoff small notes etc..) and the rest is in stock
Typically in this type of scenario the acquiring company can pay a higher premium if they pay with stock instead with cash.
Market Data 
Markets 
AI
